Evidence map›Paper›PMID 28436968›Full record

SynthesisNature cell biology2017

Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.

Young Cha, Min-Joon Han, Hyuk-Jin Cha, Janet Zoldan, Alison Burkart, Jin Hyuk Jung, Yongwoo Jang, Chun-Hyung Kim, Ho-Chang Jeong, Byung-Gyu Kim and 4 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Induced Pluripotent Stem Cells derived CD71International journal of stem cells · 2026
    Article
  5. From Pharmacophore to Warhead: NADAngewandte Chemie (International ed. in English) · 2025
    Article
  6. Article
  7. Article
  8. The role of NADnpj metabolic health and disease · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. The role of acetylation and deacetylation in cancer metabolism.Clinical and translational medicine · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Young ChaMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Min-Joon HanMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Hyuk-Jin ChaCollege of Natural Sciences, Department of Life Sciences, Sogang University, Seoul 04107, Korea.
Janet ZoldanDepartment of Chemical Engineering, David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts 02139, USA.
Alison BurkartSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Jin Hyuk JungMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Yongwoo JangMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Chun-Hyung KimMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Ho-Chang JeongCollege of Natural Sciences, Department of Life Sciences, Sogang University, Seoul 04107, Korea.ORCID http://orcid.org/0000-0002-5379-8314
Byung-Gyu KimCenter for Genomic Integrity Institute for Basic Science, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea.
Robert LangerDepartment of Chemical Engineering, David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts 02139, USA.
C Ronald KahnSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Leonard GuarenteDepartment of Biology, MIT, Cambridge, Massachusetts 02139, USA.
Kwang-Soo KimMolecular Neurobiology Laboratory, Department of Psychiatry and McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.
Harvard University · USJoslin Diabetes Center · USSogang University · KRSt. Jude Children's Research Hospital · USAllen Institute · USIIT@MIT · USInstitute for Basic Science · KR

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Protein-induced human iPS cells for personalized cell therapy of PDR01NS070577 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, KORDOWER, JEFFREY H · 2010 to 2020
$4.9M
Biorepository of iPSC lines from diverse rat strains for regenerative medicine researchR24OD024622 · OD · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, KONG, SEK WON · 2018 to 2021
$3.4M
High throughput microfluidic intracellular delivery platformR01GM101420 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ANDERSON, DANIEL G, JENSEN, KLAVS F · 2013 to 2016
$2.1M
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and DiseaseR01NS084869 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2014 to 2018
$1.7M
NIDDK NIH HHS P30 DK036836NIGMS NIH HHS R01 GM101420NIH HHS R24 OD024622NINDS NIH HHS R01 NS070577NINDS NIH HHS R01 NS084869
6 · The paper itself

Abstract

A hallmark of cancer cells is the metabolic switch from oxidative phosphorylation (OXPHOS) to glycolysis, a phenomenon referred to as the 'Warburg effect', which is also observed in primed human pluripotent stem cells (hPSCs). Here, we report that downregulation of SIRT2 and upregulation of SIRT1 is a molecular signature of primed hPSCs and that SIRT2 critically regulates metabolic reprogramming during induced pluripotency by targeting glycolytic enzymes including aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and enolase. Remarkably, knockdown of SIRT2 in human fibroblasts resulted in significantly decreased OXPHOS and increased glycolysis. In addition, we found that miR-200c-5p specifically targets SIRT2, downregulating its expression. Furthermore, SIRT2 overexpression in hPSCs significantly affected energy metabolism, altering stem cell functions such as pluripotent differentiation properties. Taken together, our results identify the miR-200c-SIRT2 axis as a key regulator of metabolic reprogramming (Warburg-like effect), via regulation of glycolytic enzymes, during human induced pluripotency and pluripotent stem cell function.

Indexed as

Cell DifferentiationEnergy MetabolismAcetylationCell LineageCell SurvivalCellular ReprogrammingComputational BiologyDatabases, GeneticGene Expression Regulation, EnzymologicGlycolysisHEK293 CellsHumansMicroRNAsOxidative PhosphorylationPhenotypePluripotent Stem CellsMicroRNAsMIRN200 microRNA, humanSIRT1 protein, humanSIRT2 protein, humanSirtuin 1Sirtuin 2

Identifiers

PMID28436968
PMCPMC5545746
OpenAlexW2608681872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.